VI
BMY icon

Vestcor Inc’s Bristol-Myers Squibb BMY Stock Holding History

Vestcor Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Sell
80,237
-8,162
-9% -$469K 0.11% 196
2026
Q1 		$5.36M Sell
88,399
-316,931
-78% -$18.5M 0.15% 147
2025
Q4 		$21.9M Hold
405,330
– – 0.62% 31
2025
Q3 		$18.3M Buy
405,330
+174,644
+76% +$8.16M 0.55% 38
2025
Q2 		$10.7M Buy
230,686
+191,560
+490% +$9.4M 0.32% 73
2025
Q1 		$2.39M Sell
39,126
-8,858
-18% -$516K 0.08% 260
2024
Q4 		$2.71M Buy
47,984
+9,157
+24% +$512K 0.09% 231
2024
Q3 		$2.01M Sell
38,827
-34,283
-47% -$1.61M 0.06% 294
2024
Q2 		$3.04M Sell
73,110
-88,395
-55% -$3.96M 0.1% 206
2024
Q1 		$8.76M Sell
161,505
-6,769
-4% -$345K 0.3% 76
2023
Q4 		$8.63M Sell
168,274
-486
-0.3% -$25.5K 0.29% 75
2023
Q3 		$9.79M Sell
168,760
-1,674
-1% -$103K 0.36% 64
2023
Q2 		$10.9M Sell
170,434
-2,615
-2% -$175K 0.4% 58
2023
Q1 		$12M Buy
173,049
+85,470
+98% +$6.03M 0.44% 50
2022
Q4 		$6.3M Buy
87,579
+33,056
+61% +$2.49M 0.23% 104
2022
Q3 		$3.88M Sell
54,523
-566
-1% -$41.1K 0.15% 160
2022
Q2 		$4.24M Buy
55,089
+19,976
+57% +$1.52M 0.16% 141
2022
Q1 		$2.56M Buy
35,113
+7,687
+28% +$516K 0.09% 254
2021
Q4 		$1.71M Sell
27,426
-5,499
-17% -$323K 0.06% 319
2021
Q3 		$1.95M Sell
32,925
-4,664
-12% -$307K 0.07% 280
2021
Q2 		$2.51M Sell
37,589
-75,485
-67% -$4.92M 0.08% 257
2021
Q1 		$7.14M Sell
113,074
-20,058
-15% -$1.25M 0.27% 112
2020
Q4 		$8.26M Buy
133,132
+5,966
+5% +$367K 0.34% 86
2020
Q3 		$7.67M Buy
127,166
+323
+0.3% +$19.4K 0.36% 79
2020
Q2 		$7.46M Buy
126,843
+76,653
+153% +$4.58M 0.39% 77
2020
Q1 		$2.8M Buy
50,190
+8,636
+21% +$528K 0.16% 160
2019
Q4 		$2.67M Buy
+41,554
New +$2.38M 0.13% 212

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vestcor Inc's BMY Position: Q2 2026 in Review

Vestcor Inc reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q2 2026, selling an estimated $469K and leaving 80,237 shares worth $4.62M. The position accounts for 0.11% of the portfolio, ranked #196.

Vestcor Inc first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $21.9M in Q4 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vestcor Inc held 80,237 shares of Bristol-Myers Squibb worth $4.62M as of Q2 2026.
  • Vestcor Inc sold 8,162 Bristol-Myers Squibb shares in Q2 2026, an estimated $469K.
  • Bristol-Myers Squibb made up 0.11% of Vestcor Inc's portfolio in Q2 2026, its #196 holding.
  • Vestcor Inc first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's Bristol-Myers Squibb position peaked at $21.9M in Q4 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.